Inventor · disambiguated record
Marc Nasoff
Also filed as: NASOFF MARC · NASOFF MARC S
18 granted patents·15 pending applications·231 citations·filing 1990–2022
93Inventor score
Files withIRM LLC7FORTIS THERAPEUTICS INC5DONG LIQUN3LIFE TECHNOLOGIES CORP3ELANCO TIERGESUNDHEIT AG2
Top patents by PatentIndex Score
33 records- 0194US8101182B2Methods and compositions for treating allergic diseasesDONG LIQUN·Filed 2008·Granted Jan 24, 2012·110 cites·11 claims
- 0288US9790280B2Monoclonal canine CD20 antibodies and methods of useELANCO TIERGESUNDHEIT AG·Filed 2012·Granted Oct 17, 2017·13 cites·7 claims
- 0388US7229617B2Methods and compositions for inducing apoptosis in cancer cellsIRM LLC·Filed 2003·Granted Jun 12, 2007·35 cites·16 claims
- 0486US8012703B2Microarrays and uses thereforLIFE TECHNOLOGIES CORP·Filed 2009·Granted Sep 6, 2011·3 cites·13 claims
- 0579US8097705B2Methods and compositions for treating allergic diseasesDONG LIQUN·Filed 2007·Granted Jan 17, 2012·5 cites·14 claims
- 0673US6635441B2Multi-sample fermentor and method of using sameIRM LLC·Filed 2001·Granted Oct 21, 2003·10 cites·27 claims
- 0772US8173128B2Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibodyNASOFF MARC·Filed 2006·Granted May 8, 2012·2 cites·17 claims
- 0872US7888483B2Antagonists of protease activated receptor-1 (PAR1)IRM LLC·Filed 2007·Granted Feb 15, 2011·2 cites·22 claims
- 0968US12144888B2Immunoconjugates targeting CD46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2022·Granted Nov 19, 2024·0 cites·19 claims
- 1067US6723555B2Multi-sample fermentor and method of using sameIRM LLC·Filed 2002·Granted Apr 20, 2004·6 cites·12 claims
- 1167US2013123127A1Microarrays and uses thereofLIFE TECHNOLOGIES CORP·Filed 2012·Application pending·0 cites
- 1267US2023035087A1Immunoconjugates targeting cd46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1365US11484604B2Immunoconjugates targeting CD46 and methods of use thereofFORTIS THERAPEUTICS INC·Filed 2021·Granted Nov 1, 2022·0 cites·4 claims
- 1462US7863008B2Method for detecting NANBV associated seroconversionBIOPROCESS PTY LTD·Filed 2008·Granted Jan 4, 2011·0 cites·20 claims
- 1559US11319377B2Monoclonal antibodies and methods of useELANCO TIERGESUNDHEIT AG·Filed 2017·Granted May 3, 2022·0 cites·15 claims
- 1659US5030563ABacterial hypersecretion using mutant repressor sequenceGENETICS INST·Filed 1990·Granted Jul 9, 1991·20 cites·6 claims
- 1758US8637264B2Microarrays and uses thereforHOEFFLER JAMES P·Filed 2011·Granted Jan 28, 2014·0 cites·4 claims
- 1857US2002164656A1Microarrays and uses thereforFiled 2001·Application pending·0 cites
- 1956US2009155772A1Method for detecting nanbv associated seroconversionZEBEDEE SUZANNE·Filed 2009·Application pending·0 cites
- 2054US6692751B1Methods and systems for producing recombinant viral antigensNEW YORK BLOOD CT INC·Filed 1997·Granted Feb 17, 2004·19 cites·14 claims
- 2152US2004157322A1Multi-sample fermentor and method of using sameIRM LLC·Filed 2004·Application pending·0 cites
- 2252US2024058464A1Combination therapy with for46 for cancerFORTIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2349US2004214163A1Methods and systems for producing recombinant viral antigensFiled 2003·Application pending·0 cites
- 2449US2023348881A1Modified serine protease proproteinsONCHILLES PHARMA INC·Filed 2021·Application pending·0 cites
- 2548US2010150914A1Agonist trkb antibodies and uses thereofIRM LLC·Filed 2007·Application pending·0 cites
- 2646US7794946B1Microarray and uses thereforLIFE TECHNOLOGIES CORP·Filed 1999·Granted Sep 14, 2010·6 cites·23 claims
- 2744US12049511B2Engineered CD46-specific effector cells and uses thereof in the treatment of cancerFORTIS THERAPEUTICS INC·Filed 2017·Granted Jul 30, 2024·0 cites·19 claims
- 2843US2012027756A1Methods and compositions for treating allergic diseasesDONG LIQUN·Filed 2011·Application pending·0 cites
- 2941US2019284274A1Erfe specific antibodies compositions and methods of useSILARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3041US2020040054A1Erfe fusion polypeptides compositions and methods of useSILARUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3141US2011158999A1Antagonists of protease activated receptor-1 (par1)IRM LLC·Filed 2011·Application pending·0 cites
- 3234US2003091473A1Automated centrifuge and method of using sameFiled 2001·Application pending·0 cites
- 3334US2002132354A1Automated centrifuge and method of using sameIRM LLC C O SOPHIA HOUSE·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Nasoff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →